Home Carboxes 1256807-59-6
1256807-59-6,MFCD18250815
Catalog No.:AA000OAV

1256807-59-6 | 1H-Pyrazolo[4,3-b]pyridine-6-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$70.00   $49.00
- +
250mg
95%
in stock  
$112.00   $79.00
- +
500mg
95%
in stock  
$210.00   $147.00
- +
1g
95%
in stock  
$245.00   $171.00
- +
5g
95%
in stock  
$1,073.00   $751.00
- +
10g
95%
in stock  
$1,932.00   $1,353.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000OAV
Chemical Name:
1H-Pyrazolo[4,3-b]pyridine-6-carboxylic acid
CAS Number:
1256807-59-6
Molecular Formula:
C7H5N3O2
Molecular Weight:
163.1335
MDL Number:
MFCD18250815
SMILES:
OC(=O)c1cc2[nH]ncc2nc1
Properties
Computed Properties
 
Complexity:
197  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
0.1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:PFIZERINC-US2011/111046,2011,A1

[2]CurrentPatentAssignee:PFIZERINC-WO2011/58473,2011,A1

[3]CurrentPatentAssignee:PFIZERINC-US2012/108619,2012,A1

[1]Patent:US2011/111046,2011,A1

[2]Patent:WO2011/58473,2011,A1

[3]Patent:WO2013/127266,2013,A1

[4]Patent:WO2013/127267,2013,A1

[5]Patent:WO2013/130935,2013,A1

[6]Patent:WO2013/130943,2013,A1

[7]Patent:US2012/108619,2012,A1

[1]CurrentPatentAssignee:PFIZERINC-US2011/111046,2011,A1

[2]CurrentPatentAssignee:PFIZERINC-WO2011/58473,2011,A1

[3]CurrentPatentAssignee:VALOHEALTHINC-WO2013/127266,2013,A1

[4]CurrentPatentAssignee:VALOHEALTHINC-WO2013/127267,2013,A1

[5]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.;ROCHEHOLDINGAG-WO2013/130935,2013,A1

[6]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.;ROCHEHOLDINGAG-WO2013/130943,2013,A1

[7]CurrentPatentAssignee:PFIZERINC-US2012/108619,2012,A1

[1]Patent:US2011/111046,2011,A1

[2]Patent:WO2011/58473,2011,A1

[3]Patent:US2012/108619,2012,A1

[1]CurrentPatentAssignee:PFIZERINC-US2011/111046,2011,A1

[2]CurrentPatentAssignee:PFIZERINC-WO2011/58473,2011,A1

[3]CurrentPatentAssignee:VALOHEALTHINC-WO2013/127266,2013,A1

[4]CurrentPatentAssignee:VALOHEALTHINC-WO2013/127267,2013,A1

[5]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.;ROCHEHOLDINGAG-WO2013/130935,2013,A1

[6]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.;ROCHEHOLDINGAG-WO2013/130943,2013,A1

[7]CurrentPatentAssignee:PFIZERINC-US2012/108619,2012,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1256807-59-6 Molecular Formula|1256807-59-6 MDL|1256807-59-6 SMILES|1256807-59-6 1H-Pyrazolo[4,3-b]pyridine-6-carboxylic acid